Frontier Biotechnologies (SHSE:688221) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688221 Frontier Biotechnologies Inc SHSE:688221
67 GF Score
Price ¥19.46
GF Value ¥37.46
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Frontier Biotechnologies Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Frontier Biotechnologies's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHSE:688221 vs ZTS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Frontier Biotechnologies's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Frontier Biotechnologies Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Frontier Biotechnologies's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Frontier Biotechnologies's Margin of Safety % (DCF Earnings Based) falls into.


SHSE:688221
67GF Score
Frontier Biotechnologies Inc SHSE:688221
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Frontier Biotechnologies (SHSE:688221) Overvalued in 2026?

Based on GuruFocus' analysis, Frontier Biotechnologies stock appears to be undervalued. The current stock price of ¥19.46 is trading 48.1% below its estimated GF Value™ of ¥37.46. GuruFocus considers Frontier Biotechnologies to be Significantly Undervalued.

Key valuation signals for SHSE:688221:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥37.46 vs. price of ¥19.46 (48.1% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688221 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Frontier Biotechnologies Business Description

Address Dongshan Street, 11th Floor, Building E-2, Greenland Window, Jiangning District, Jiangsu Province, Nanjing, CHN, 211199
Frontier Biotechnologies Inc is engaged in the Research, development, production, and marketing of inventive drugs that address unmet clinical needs.
67GF Score

Get the complete analysis for SHSE:688221

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.46
Price
¥37.46
GF Value